PPARA and breast carcinoma: Also, on experimental basis, nuclear receptor agonists, like PPARα/γ agonists combined with all-trans retinoic acid unfold activity by modeling stroma and tumor cells, thereby reducing aromatase activity in neighboring fat cells in the breast and negatively impact breast cancer stem cell survival (129, 130).